Insider Transactions in Q2 2025 at Humacyte, Inc. (HUMA)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 14
2025
|
William John Scheessele Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
6,493
+22.77%
|
$6,493
$1.54 P/Share
|
|
Apr 10
2025
|
Shamik J Parikh Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
7,500
+50.0%
|
$7,500
$1.55 P/Share
|
|
Apr 10
2025
|
Dale A. Sander CFO and Chief Corp. Deve. Off. |
BUY
Open market or private purchase
|
Indirect |
20,000
+33.0%
|
$20,000
$1.53 P/Share
|
|
Apr 08
2025
|
Charles Bruce Green Director |
BUY
Open market or private purchase
|
Direct |
6,000
+41.67%
|
$6,000
$1.29 P/Share
|
|
Apr 08
2025
|
Kathleen Sebelius Director |
BUY
Open market or private purchase
|
Direct |
50,000
+35.41%
|
$50,000
$1.32 P/Share
|
|
Apr 07
2025
|
Michael T. Constantino Director |
BUY
Open market or private purchase
|
Direct |
16,000
+32.69%
|
$16,000
$1.26 P/Share
|